1/24/17 – Speaking to her bill, SB1403, which directs the Board of Pharmacy to initiate action to deschedule or reschedule cannabidiol or any product containing cannabidiol that has been approved as a prescription medication by the U.S. Food and Drug Administration within 90 days of publication in the Federal Register of an interim final rule.